Retail News

Studies Show Pfizer’s New Anti-Smoking Drug More Effective

UPI 07/05/2006

In one recent study, Chantix, a new anti-smoking remedy to be sold by Pfizer, showed better results among 44 percent of smokers tested as compared with rival bupropion, marketed under the brands Zyban and Wllbutrin.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!